Yuko Ohno

Prof. Yuko Ohno

Division of Robotics and Design for Innovative Healthcare, School of Medicine, Osaka University, Osaka Prefecture 565-0871, Japan
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Nurse Education Today
Verified
Journal Article
Open access
TTTomoko Tamaki
Tomoko Tamaki
AIAnri Inumaru
Anri Inumaru
YYYumie Yokoi
Yumie Yokoi
MFMakoto Fujii
Makoto Fujii
MTMayu Tomita
Mayu Tomita
MTMayumi Tsujikawa
Mayumi Tsujikawa
Nursing students have limited opportunities to experience end-of-life care, so it is difficult for them to learn how to deliver it empirically. The use of simulations with standardized patients may be a way to provide realistic experience of end-of-life care for nursing students. The aim of this study was to evaluate the effectiveness of end-of-life care simulations with standardized patients in improving the knowledge, skill performance and self-confidence of undergraduate nursing students. Randomized controlled study. Japanese university nursing school. Thirty-eight students in the third year of the Bachelor's degree in nursing (simulation group = 20, control group = 18). After randomization to a simulation or control group, participants in the simulation group participated in an end-of-life care simulation with standardized patients. The primary outcome of a change in the knowledge score was assessed using a knowledge questionnaire, skill performance by completing Objective Structured Clinical Evaluations, and self-confidence related to end-of-life care by self-reported questionnaires. The simulation group improved significantly in knowledge, skill performance in physical assessment and psychological care, and self-confidence related to end-of-life care. The results of the two-way analysis of variance showed a significant interaction between groups and time (p = 0.000). Analysis of the simple main effect showed a significant difference (p = 0.000) between groups after the end-of-life care simulation and a significant difference (p = 0.000) over time in the simulation group. There were large effects on knowledge improvement (η2 = 0.372), physical assessment (η2 = 0.619), psychological care skill performance (η2 = 0.588), and self-confidence in both physical assessment (η2 = 0.410) and psychological care (η2 = 0.722). End-of-life care simulation with standardized patients would be an effective strategy to train nursing students, who have limited opportunities to experience end-of-life care.

1 October 2014 in Cancer Epidemiology
Verified
Journal Article
Open access
TTTomoko Tamaki
Tomoko Tamaki
YDYiqi Dong
Yiqi Dong
Yuko OhnoYuko Ohno
Yuko Ohno
TSTomotaka Sobue
Tomotaka Sobue
HNHiroshi Nishimoto
Hiroshi Nishimoto
ASAkiko Shibata
Akiko Shibata
Despite the fact that rare cancer is a new target of cancer control in Japan, the incidence of rare cancers is unknown and there is no generally accepted definition of rare cancers in this country. With the aim of calculating incidences of rare cancers in Japan, we therefore adopted a definition and classification of rare cancers that had been published in the European Union (EU) in 2011. Using incidence data between 1998 and 2007 submitted by 12 of population based cancer registries in Japan that met our quality criteria and drawing on the EU definition (incidence <6 per 100,000 per year), we estimated the incidences of 845 combinations of tumor sites and histological groups and thus identified the cancers that are rare in Japan. After identifying 193 combinations of tumor sites and histological groups that fit our criteria for rare cancers, we estimated their incidence to be about 75 per 100,000, which corresponds to about 94,800 new diagnoses in 2012 or approximately 15% of all cancer diagnoses. The categorization of rare and common cancers was almost the same in Japan as in EU. The present study provides an indication of the size of the rare cancer burden in Japan and epidemiological information to explore this. We are expecting further discussion based on our results with stakeholders in order to construct a Japanese definition of rare cancers.

7 February 2019 in Environmental Health and Preventive Medicine
Verified
Journal Article
Open access
PDF file
MFMakoto Fujii
Makoto Fujii
Yuko OhnoYuko Ohno
Yuko Ohno
MYMakoto Yamada
Makoto Yamada
Yoshihiro KamadaYoshihiro Kamada
Yoshihiro Kamada
Eiji MiyoshiEiji Miyoshi
Eiji Miyoshi
Although fat accumulation in human organs is associated with a variety of diseases, there is little evidence about the effect of a fatty pancreas on the development of subclinical chronic pancreatitis over the clinical course. We conducted a prospective cohort study from 2008 to 2014 of patients who underwent a medical checkup consultation for fat accumulated in the pancreas. Patients included in the analysis were divided into a non-fatty pancreas group (n = 9710) and fatty pancreas group (n = 223). The primary end point was the odds ratio (OR) for chronic pancreatitis associated with fatty pancreas, which was diagnosed using ultrasonography. We used a multiple logistic regression model to estimate the OR and the corresponding 95% confidence interval (CI). Ninety-two people were diagnosed with chronic pancreatitis, including both presumptive and definitive diagnoses. Twelve people were diagnosed with chronic pancreatitis by ultrasonography among the 223 patients with fatty pancreas, and 80 patients among 9710 were diagnosed with non-fatty pancreas. The crude OR was 6.85 (95% CI 3.68, 12.75), and the multiple adjusted OR was 3.96 (95% CI 2.04, 7.66). Fat accumulation in the pancreas could be a risk factor for developing subclinical chronic pancreatitis.

1 January 2018 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
YTYukako Tatsumi
Yukako Tatsumi
AMAkiko Morimoto
Akiko Morimoto
KAKei Asayama
Kei Asayama
NSNao Sonoda
Nao Sonoda
NMNaomi Miyamatsu
Naomi Miyamatsu
TOTakayoshi Ohkubo
Takayoshi Ohkubo

5 December 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
YGYasufumi Gon
Yasufumi Gon
LZLing Zha
Ling Zha
TSTsutomu Sasaki
Tsutomu Sasaki
TMToshitaka Morishima
Toshitaka Morishima
Yuko OhnoYuko Ohno
Yuko Ohno
IMIsao Miyashiro
Isao Miyashiro
Background: Data on the risk of cardiovascular‐related mortality in patients with cancer are limited. Methods and Results: This retrospective cohort study used data from the Osaka Cancer Registry and vital statistics in Japan between 1985 and 2013. The causes of death were investigated, and the risk of fatal heart disease was analyzed. Standardized mortality ratios were calculated to compare the risk of fatal heart disease between patients with cancer and the general population. Fine and Gray competing risk regression models were used to assess the risk of fatal heart disease among patients with cancer. In total, 682 886 patients with cancer were included in the analysis, and 335 635 patients died during the study period. Heart disease was the leading cause of noncancer deaths, with 10 686 deaths. Among the patients who died of heart disease, 5017 had ischemic heart disease, 3598 had heart failure, 356 had hypertensive disease, and 1715 had other heart diseases. The standardized mortality ratio for heart disease was 2.80 (95% CI, 2.74–2.85). The standardized mortality ratio for ischemic heart disease, heart failure, and hypertensive disease were 3.26 (95% CI, 3.17–3.35), 2.69 (95% CI, 2.60–2.78), and 5.97 (95% CI, 5.38–6.63), respectively. The risk of fatal heart disease increased over time after cancer diagnosis. Men were more likely to die of heart disease than women (subdistribution hazard ratio, 1.08 [95% CI, 1.02–1.16]). The risk of fatal heart disease among cancer survivors has decreased in recent years. Conclusions: Cancer survivors have a higher risk of fatal heart disease than the general population.

6 January 2020 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
ZWZehua Wang
Zehua Wang
JGJianwen Gao
Jianwen Gao
Yuko OhnoYuko Ohno
Yuko Ohno
HLHaiou Liu
Haiou Liu
CXCongjian Xu
Congjian Xu